89.76
price up icon1.27%   1.13
after-market Dopo l'orario di chiusura: 89.76
loading

Gilead Sciences Inc Borsa (GILD) Ultime notizie

pulisher
05:18 AM

Layoff Tracker: J&J, Merck Trimming Workforces in China - BioSpace

05:18 AM
pulisher
03:43 AM

Sjogren’s Syndrome Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Gilead Sciences, Incyte Corporation, Novartis, GlaxoSmithKline, Janssen Research & Development - Barchart

03:43 AM
pulisher
12:02 PM

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $100.00 - MarketBeat

12:02 PM
pulisher
10:50 AM

Gilead’s GS-6791 ameliorates arthritis symptoms in mice - BioWorld Online

10:50 AM
pulisher
07:09 AM

Intech Investment Management LLC Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

07:09 AM
pulisher
05:12 AM

PNC Financial Services Group Inc. Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

05:12 AM
pulisher
03:59 AM

Gilead Sciences, Inc. (NASDAQ:GILD) Position Increased by Natixis Advisors LLC - MarketBeat

03:59 AM
pulisher
03:31 AM

Latham & Watkins Advises on Gilead Sciences' US$3.5 Billion Senior Unsecured Notes Offering - Legal Desire News Network

03:31 AM
pulisher
Nov 20, 2024

Watkins Advises on Gilead Sciences' US$3.5 Billion Senior Unsecured Notes Offering - Latham & Watkins LLP

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences (GILD) Announces Issuance of Senior Notes in New Indenture Agreement - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences Issues $3.5 Billion in Senior Notes - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer - CSRwire.com

Nov 20, 2024
pulisher
Nov 20, 2024

How Gilead Is Driving Global Health Equity And Innovation - Forbes

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by First Horizon Advisors Inc. - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Science to Report Q3 Earnings: What's in the Cards? - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Ontario Teachers Pension Plan Board - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

B. Metzler seel. Sohn & Co. Holding AG Takes $9.52 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Prospera Financial Services Inc Has $6.59 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Gilead discloses GS-441524 prodrugs for treatment of viral infections - BioWorld Online

Nov 19, 2024
pulisher
Nov 19, 2024

Ideaya hires Gilead leader to head up commercialization push - FiercePharma

Nov 19, 2024
pulisher
Nov 19, 2024

Parnassus Investments LLC Sells 280,937 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Meeder Asset Management Inc. Purchases 42,444 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Belmont Capital LLC Reduces Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Gilead Sciences Inc. stock rises Monday, still underperforms market - MarketWatch

Nov 18, 2024
pulisher
Nov 18, 2024

Gilead announces impending layoffs, facility closure - LabPulse

Nov 18, 2024
pulisher
Nov 18, 2024

26 Analysts Assess Gilead Sciences: What You Need To Know - Benzinga

Nov 18, 2024
pulisher
Nov 18, 2024

Royal Bank of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Amid Seattle downsizing, Gilead cuts 100+ positions at California HQ - FiercePharma

Nov 18, 2024
pulisher
Nov 18, 2024

Gilead’s Livdelzi shows promise in PBC clinical trial - Yahoo Finance

Nov 18, 2024
pulisher
Nov 18, 2024

Gilead Sciences shares target upgraded, holds rating on HIV event outlook - Investing.com India

Nov 18, 2024
pulisher
Nov 18, 2024

5,715 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Aljian Capital Management LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by TrinityPoint Wealth LLC - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Empowering women, eliminating viral hepatitis: Gilead’s vision to help drive public health solutions - STAT

Nov 18, 2024
pulisher
Nov 18, 2024

Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis - BioSpace

Nov 18, 2024
pulisher
Nov 17, 2024

Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 - GlobeNewswire Inc.

Nov 17, 2024
pulisher
Nov 17, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Swiss National Bank - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Thrivent Financial for Lutherans Boosts Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

14,342 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Atlanta Consulting Group Advisors LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

GILEAD SCIENCES, INC. (GILD) - MSN

Nov 17, 2024
pulisher
Nov 16, 2024

How Gilead Sciences' HIV & Other Innovations Are Set to Capture Untapped Markets & Drive Massive Growth!Major Drivers - Smartkarma

Nov 16, 2024
pulisher
Nov 16, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Kentucky Retirement Systems - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

CIBC Asset Management Inc Purchases 22,624 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Impax Asset Management Group plc Sells 7,979 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Gilead’s Irish business sees profit slump on falling sales of Covid drug - The Irish Times

Nov 16, 2024
pulisher
Nov 15, 2024

Gilead to see Bay Area layoffs in wake of Seattle office closingSan Francisco Business Times - The Business Journals

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Form 424B5 GILEAD SCIENCES, INC. - StreetInsider.com

Nov 15, 2024
pulisher
Nov 15, 2024

Biotech giant Gilead lays off 104 from Bay Area headquarters, including execs - SFGATE

Nov 15, 2024
pulisher
Nov 15, 2024

Cell Therapy Market Poised for Massive Growth (2024-2031) | Gilead Sciences, Inc., Novartis, AG, Vericel Corporation - openPR

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Simplify Asset Management Inc. Buys New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead Sciences (GILD) Reports Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis - StreetInsider.com

Nov 15, 2024
pulisher
Nov 15, 2024

Empowered Funds LLC Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

As an HIV+ activist, I know drug companies aren't doing enough to end AIDS - Yahoo News UK

Nov 15, 2024
pulisher
Nov 15, 2024

Dearborn Partners LLC Has $26.76 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Intellectus Partners LLC - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Citigroup Upgrades Gilead Sciences (NASDAQ:GILD) to Strong-Buy - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead and Kite Are Cutting Employees, Closing Seattle, Philadelphia Sites - BioSpace

Nov 15, 2024
pulisher
Nov 15, 2024

Gilead Sciences to close Seattle office; shutdown impacts 72 employees - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

COVID drugmaker to close Seattle office, lay off 72 workers - The Seattle Times

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead Sciences Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Market on Track for Major Expansion by 2034, According to DelveInsight | Eli Lilly and Company, Gilead Sciences, Novartis, Autolus Therapeutics - Barchart

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead, Vertex initiated as new big biotech buys at Citi - Seeking Alpha

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead lays off 72 workers in Seattle, plans to shutter R&D support site - Fierce Biotech

Nov 14, 2024
pulisher
Nov 14, 2024

ING Groep NV Acquires 109,788 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead Sciences to Close Seattle Office, Lay Off 72 Employees Located at Alexandria’s 199 E. Blaine Property - The Registry Seattle

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by KBC Group NV - MarketBeat

Nov 14, 2024
drug_manufacturers_general BMY
$58.23
price up icon 0.60%
drug_manufacturers_general SNY
$47.98
price up icon 0.42%
drug_manufacturers_general PFE
$25.13
price up icon 0.76%
$289.90
price up icon 0.71%
drug_manufacturers_general NVS
$103.85
price up icon 0.74%
drug_manufacturers_general MRK
$99.86
price up icon 2.48%
Capitalizzazione:     |  Volume (24 ore):